logo
logo

Arcaea, A Company Launched On The Ginkgo Bioworks Platform, Announces $78M Series A To Build A New Foundation For The Beauty Industry Through Expressive Biology

Oct 27, 2021•almost 4 years ago

Amount Raised

$78 Million

Round Type

series a

Boston

Description

Arcaea (Ar-kay-uh), a company launched on the Ginkgo Bioworks (NYSE: DNA) Platform, today announced its $78M Series A to build a new, regenerative future for the beauty industry through expressive biology—where biology is used as a creative tool for self-expression. Arcaea will grow new ingredients and product experiences for beauty by leveraging technology such as DNA sequencing, biological engineering, and fermentation to activate unique storytelling.

Company Information

Company

Arcaea (Ar Kay Uh)

Location

Boston, Massachusetts, United States

About

Arcaea, LLC (Ar-kay-uh), a company launched on the Ginkgo Bioworks platform, with the mission to build a new foundation for the beauty industry through expressive biology. Arcaea sees biology as a valuable creative tool for self expression. The company will grow new ingredients and product experiences for beauty through technology such as DNA sequencing, biological engineering, fermentation and more. By culturing industry-leading, safe, and sustainable ingredients, Arcaea intends to create a new supply chain for the industry that does not rely on petrochemicals or on harvesting and depleting natural resources. By harnessing the power of biology, Arcaea is poised to produce highly sustainable products that can deliver new functionality and performance across skincare, bodycare, haircare, and aesthetics. Arcaea was incubated on the Ginkgo Bioworks platform and formed under the name Kalo Ingredients LLC.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech